1 Clinically important upper GI bleeding |
3 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 Sucralfate vs omeprazole |
3 |
287 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.58 [0.77, 8.63] |
2 Nosocomial pneumonia |
4 |
424 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.41, 1.09] |
2.1 Sucralfate vs omeprazole |
3 |
287 |
Risk Ratio (M‐H, Random, 95% CI) |
0.88 [0.57, 1.36] |
2.2 Sucralfate vs pantoprazole |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.39 [0.20, 0.75] |
3 All‐cause mortality in ICU |
4 |
424 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.07 [0.68, 1.68] |
3.1 Sucralfate vs omeprazole |
3 |
287 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.26 [0.75, 2.11] |
3.2 Sucralfate vs pantoprazole |
1 |
137 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.65 [0.25, 1.68] |
4 All‐cause mortality in hospital |
2 |
278 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.79 [0.46, 1.37] |
4.1 Sucralfate vs omeprazole |
1 |
141 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.97 [0.49, 1.91] |
4.2 Sucralfate vs pantoprazole |
1 |
137 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.56 [0.21, 1.45] |
5 Duration of ICU stay |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
5.1 Sucralfate vs omeprazole |
2 |
217 |
Mean Difference (IV, Fixed, 95% CI) |
0.01 [‐1.68, 1.70] |
6 Duration of intubation |
3 |
354 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.16 [‐1.61, 1.28] |
6.1 Sucralfate vs omeprazole |
2 |
217 |
Mean Difference (IV, Fixed, 95% CI) |
0.02 [‐1.56, 1.60] |
6.2 Sucralfate vs pantoprazole |
1 |
137 |
Mean Difference (IV, Fixed, 95% CI) |
‐1.10 [‐4.69, 2.49] |
7 Number of participants requiring blood transfusion |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
7.1 Sucralfate vs omeprazole |
1 |
70 |
Risk Ratio (M‐H, Fixed, 95% CI) |
5.91 [0.29, 118.78] |
8 Adverse events of interventions |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
8.1 Fever |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.70, 0.94] |
8.2 Leucocytosis |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.66 [0.55, 0.80] |
8.3 Sudden purulent sputum |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.85 [0.38, 1.86] |
8.4 Sudden cough or aggravation of coughing |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.23 [0.07, 0.79] |
8.5 Dyspnoea |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.68 [0.54, 0.87] |
8.6 Rales or bronchial sounds |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.31 [0.19, 0.51] |
8.7 Aggravation of blood gas exchange |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.76 [0.49, 1.18] |
8.8 Change in sputum quality |
1 |
137 |
Risk Ratio (M‐H, Random, 95% CI) |
0.23 [0.13, 0.40] |